Sedergine Vit-C

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Sedergine Vit-C

Sedergine Vit-C: Quick Identity Overview

Property Description
Active Ingredients Acetylsalicylic Acid (ASA) and Ascorbic Acid (Vitamin C)
Form Effervescent Tablet
Pharmacological Class Analgesic/Antipyretic/NSAID + Vitamin Supplement
Common Use Symptomatic relief of pain and fever; Vitamin C supplementation
Origin Predominantly Synthetic

Sedergine Vit-C is a combination medicinal product administered as an effervescent tablet for oral administration. This unique, rapidly dissolving form distinguishes it from standard coated tablets, providing a quicker route for the body to access its active components. It is pharmacologically classified as an analgesic, antipyretic, and anti-inflammatory agent combined with a water-soluble vitamin supplement.


What Is Sedergine Vit-C Made Of? (Active Ingredients and Origin)

The preparation contains two primary active pharmaceutical ingredients (APIs): Acetylsalicylic Acid (ASA) and Ascorbic Acid. The combination is clinically recognized for addressing symptoms of general discomfort where pain or fever co-exists with a need for nutritional support. Acetylsalicylic Acid, a component of the non-steroidal anti-inflammatory drug (NSAID) class, is highly effective for relieving general aches and fever.

The second component, Ascorbic Acid (Vitamin C), is an essential water-soluble vitamin and powerful antioxidant. The inclusion of Vitamin C supports general well-being and is necessary for various bodily functions, including immune response and wound healing. This brand’s formulation is specifically positioned to offer dual action, combining the established benefits of pain relief with the supportive role of Vitamin C. Both of these compounds are primarily sourced via controlled synthetic processes to ensure pharmaceutical consistency.


Primary Therapeutic Focus (General Purpose)

The general therapeutic purpose of Sedergine Vit-C is to provide symptomatic relief for minor discomforts while supporting overall health through nutritional supplementation. Its typical use involves addressing common, temporary physical discomforts, such as those associated with the early stages of a cold or flu, where fever, aches, and general fatigue are present. This makes the product suitable when relief is needed and an accompanying vitamin boost is desired.

Advertisements

What side effects are possible with Sedergine Vit-C?

Possible Side Effects and Safety Information

The safety profile of Sedergine Vit-C, which contains Ascorbic Acid (Vitamin C), primarily documents adverse effects that are dose-dependent or related to pre-existing health conditions.

Adverse Reactions

Adverse reactions associated with the use of Ascorbic Acid are generally categorized into the following system-organ classes:

  • Gastrointestinal Disorders: The most commonly reported effects, typically associated with doses above 1 gram per day, include nausea, vomiting, abdominal cramps, and diarrhea.
  • Nervous System Disorders: Headache.
  • Vascular/Skin: Facial flushing and redness of the skin.
  • Renal/Urinary: Increased urination (diuresis) is noted, particularly with higher doses.

Serious and Clinically Significant Safety Concerns

Serious adverse reactions are rare and largely confined to specific, susceptible populations:

Condition Associated Risk (High Doses) Safety Restriction
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Haemolytic Anaemia (destruction of red blood cells) Use with caution; high doses are contraindicated.
History of or Risk of Kidney Stones (Hyperoxaluria) Formation of Renal Oxalate Calculi (kidney stones) Intake should be restricted to below 1 gram daily.

Safety Restrictions and Context of Use

Ascorbic Acid is contraindicated in individuals with known hypersensitivity to the drug substance and in patients diagnosed with hyperoxaluria. Caution is advised for use in patients with impaired renal function.

High doses (typically 2 grams or more per day) of Ascorbic Acid may interfere with the results of several clinical laboratory tests, including measurements for urinary glucose, uric acid, and tests for faecal occult blood, potentially leading to false readings. Use should be noted prior to any such testing.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Sedergine Vit-C overdose is defined by the documented spectrum of salicylate toxicity. Overdose manifestations may initially include symptoms of mild salicylism, such as tinnitus (ringing in the ears), hearing impairment, nausea, vomiting, and hyperventilation (rapid or deep breathing). These effects stem from systemic disturbances, including early respiratory alkalosis and subsequent metabolic acidosis.

Progression to severe overdose is documented to involve life-threatening outcomes. These complications include Central Nervous System (CNS) effects such as pronounced confusion, seizures, and coma. Other severe consequences officially noted are non-cardiogenic pulmonary edema and acute renal failure.

Regulators emphasize that immediate medical attention must be sought for any suspected overdose, as no specific antidote is known for salicylate poisoning. Management is strictly symptomatic and supportive, involving procedural steps like the administration of activated charcoal and the correction of the body’s acid-base status. Hospitalization and continuous monitoring, including serial checks of serum salicylate concentration, are required to manage potential complications. Pediatric patients are noted to have a higher risk for rapid onset of severe metabolic acidosis in overdose scenarios.

Advertisements

Therapeutic Uses of Sedergine Vit-C

What Sedergine Vit-C Treats: Main Uses and Benefits

Sedergine Vit-C is used in situations involving certain distressing symptoms, primarily for the symptomatic relief of elevated body temperature and pain. It is commonly used across conditions presenting with acute episodes where symptoms may intensify temporarily, such as those associated with the onset of seasonal colds and flu. It is applied across therapeutic domains where short-term symptom management is appropriate for fever and pain, helping to reduce fever and ease mild to moderate aches like headache, toothache, and general body pain.

The combination is relevant in contexts involving heightened systemic burden, as it helps address symptom clusters that interfere with daily comfort. The combination is relevant in contexts marked by increased discomfort or tension, as it also addresses nutritional needs. This essential nutrient supports general well-being during symptomatic phases.

Indications: The medicine is applied in addressing fever, mild to moderate aches, symptoms related to seasonal respiratory illness, and conditions requiring supportive nutritional supplementation.

“The combination is commonly used when symptoms such as fever and aches become more noticeable, requiring supportive symptomatic assistance.”


Quick Fact: Use in Acute Symptomatic Periods

Sedergine Vit-C is commonly used to help with symptomatic relief of fever and mild to moderate pain, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus overview of Aspirin
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Sedergine Vit-C? (Official Regulatory Information)

Official regulatory documents define strict population eligibility for Sedergine Vit-C, a combination of Acetylsalicylic Acid (ASA) and Ascorbic Acid. Use is established for the adult population and adolescents ge 16 years of age in the absence of contraindications.


Absolute Contraindications

The medicine is prohibited for use in individuals with:

  • Hypersensitivity to ASA, other salicylates, or Ascorbic Acid.
  • Active gastrointestinal ulcers or bleeding disorders (haemorrhagic diathesis).
  • Severe failure of the liver, kidneys, or uncontrolled heart failure.
  • A history of asthma induced by ASA or NSAIDs.
  • Nephrolithiasis, Hyperoxaluria, or Haemochromatosis.

Age and Pregnancy Status

Population Group Eligibility Status (as per Official Labeling)
Children & Adolescents (<16) Not recommended for feverish illness (risk of Reye's Syndrome).
Last (Third) Trimester of Pregnancy Contraindicated (prohibited).
First/Second Trimesters Conditional use only if clearly necessary (restricted dose and duration).
Lactation/Breastfeeding Conditional use (allowed for short-term, low-dose use only).

Conditional Use and Restrictions

Use requires special consideration and caution in patients with impaired (non-severe) hepatic or renal function, Gout, G6PD deficiency, or those on a low-sodium diet (due to the effervescent formulation).

Advertisements

What should I know about interactions with other medicines?

Sedergine Vit-C Interactions with other medicines and products

This section documents interaction patterns for Sedergine Vit-C, based strictly on regulatory labeling for its components, Acetylsalicylic Acid (ASA) and Ascorbic Acid.

Interacting Substance/Class Official Regulatory Concern
Methotrexate (High Dose) Contraindicated due to reduced renal clearance of Methotrexate, increasing its toxic plasma exposure.
Anticoagulants / Antiplatelet Agents Increased risk of hemorrhage resulting from an additive effect on blood clotting function.
Valproic Acid Increased plasma concentration of Valproic Acid through displacement from protein binding sites.
Diuretics / Antihypertensives Potential for ASA to diminish the antihypertensive and natriuretic effects, reducing efficacy.
Urine pH-Altering Agents Ascorbic Acid can acidify the urine, which may alter the excretion rate and subsequent serum levels of certain co-administered medicinal products.

Interactions with substances that affect blood clotting, such as SSRIs and Herbal Products with anti-hemostatic properties, are documented to increase the likelihood of bleeding. Systemic Glucocorticoids may decrease ASA plasma concentrations due to enhanced elimination. A mandatory time separation is required between ASA and Ibuprofen to prevent the NSAID from interfering with ASA's documented anti-platelet activity. Co-administration with Ethanol (Alcohol) is noted to increase the risk of gastrointestinal bleeding. The regulatory profile specifically notes that the risk of severe hemorrhage from ASA interactions with anticoagulants is heightened in elderly patients.

Advertisements

Mechanism of Action

The pharmacological action of the product is driven by two distinct mechanisms. Acetylsalicylic Acid (ASA) acts as an irreversible inhibitor of the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). This fundamental mechanism prevents the synthesis of prostaglandins ( PGE2) from arachidonic acid. Peripherally, this alters the eicosanoid signaling that promotes the sensitization of nociceptors. Centrally, the inhibition of PGE2 production within the hypothalamus prevents the pathological elevation of the body’s core temperature set-point. This action permits the return of the thermal set-point to a baseline, consequently initiating physiological heat-loss mechanisms. The second component, Ascorbic Acid (Vitamin C), functions as a water-soluble antioxidant, neutralizing Reactive Oxygen Species (ROS) and reducing cellular oxidative stress. This mechanism complements ASA's targeted enzymatic inhibition by contributing to the reduction of the systemic oxidative load and serving as a cofactor for several biosynthetic pathways.

Advertisements

Dosage and Administration Information

How to use Sedergine Vit-C: Official Administration Guidelines

Sedergine Vit-C, a combination of Acetylsalicylic Acid (ASA) and Ascorbic Acid, is administered according to standardized regimens.


Administration Scope

Instruction Detail
Route of administration Oral use only.
Dosing schedule Single Dose: 1 to 2 effervescent tablets. Maximum Daily Dose: Not to exceed 6 tablets (or 2,400 mg ASA)
Timing in relation to meals (if applicable) Must not be taken on an empty stomach.
Preparation requirements (if applicable) The effervescent tablet must be dissolved completely in a glass of water before taking.
Age-group administration rules Standard dosing is reserved for individuals over 15 years of age.
Missed-dose rules Not explicitly detailed for this as-needed, acute-use medicine.
Special procedural conditions The high sodium content in the effervescent tablet must be factored into the diet of patients requiring sodium control.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral solution preparation.
Frequency pattern As-needed (prn) use, with a required interval of 4 to 8 hours between doses.
Basis Follows standards for combination analgesic and vitamin supplements.
Use-context constraints Use for pain or fever is limited to a maximum of 4 consecutive days for self-treatment.

Resulting Procedural Structure

Official step sequence:

  • Completely dissolve the necessary dose of 1 to 2 effervescent tablets in a full glass of water.
  • Consume the resulting solution immediately, ensuring intake does not occur on an empty stomach.
  • Repeat the dose, if necessary, only after a minimum interval of 4 hours has passed, strictly adhering to the maximum daily dose of 6 tablets.

Connection to the overall use protocol (2–4 sentences): The official usage protocol defines the medicine as a short-term, acute treatment, structurally limiting continuous intake to four days. This requires specific patient constraints, including the mandatory dilution step to ensure proper oral administration and adherence to dose ceilings (maximum 6 tablets daily).

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sedergine Vit-C


Evidence for Symptomatic Relief of Minor Pain and Fever

Short-term randomized trials have been used in research exploring how outcomes related to physical discomfort and systemic or functional imbalance change over time. These studies were conducted during periods of increased symptom activity, primarily examining populations experiencing acute symptoms such as fever and headache.

Studies monitored changes measured during the study period for these acute, temporary symptoms. Findings describe patterns observed when the combination product was evaluated against a placebo, and the evidence reports on short-term changes in symptom intensity over defined, short time intervals, often within the first few hours of administration. Studies monitored patient-reported outcomes describing perceived discomfort.

Evidence for Symptomatic Relief of Cold and Flu Symptoms

Studies explored the use of the product for conditions characterized by fluctuating or episodic manifestations, specifically the temporary symptoms associated with the common cold, such as aches, pains, and general discomfort. Research examined short-term symptom changes and outcomes reflecting daily functioning or activity level, utilizing validated measures.

Research examined patterns observed in the studies where the combination was evaluated in adult populations with recent-onset symptoms. Studies report how some symptoms evolved in the observed populations, with certain research indicating changes in patient-reported severity compared to placebo over a very short duration. Additionally, research on the Vitamin C component alone suggests that regular intake was observed in some studies to report patterns of difference in the duration and severity of cold episodes.


What Is Still Uncertain About Sedergine Vit-C

Evidence highlights what is known—and what is still uncertain—about the precise influence of the combination beyond the short-term outcomes related to acute symptoms. Follow-up durations were limited across many trials, and sample sizes were modest for some specific investigations, meaning long-term findings are not fully established.

Data for certain groups remain limited. For instance, few data are available to describe the impact of the combined product on pediatric patients or pregnant populations. Comparative evidence is lacking for the use of this specific combination versus other symptomatic treatments. The study results reflect the specific conditions under which they were conducted, and research does not determine whether an individual will respond similarly to the group patterns described in the studies.

Key Studies & References

  1. Biowaiver monograph for immediate-release solid oral dosage forms: Acetylsalicylic acid
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sedergine Vit-C (FAQ)


Q: Is Sedergine Vit-C the same as just taking a Vitamin C tablet?

According to the official product information, Sedergine Vit-C is a combination medicine containing two active components. It includes Ascorbic Acid (Vitamin C), but it also contains Acetylsalicylic Acid (ASA), which is a component of a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and fever. A standard Vitamin C tablet typically contains only Ascorbic Acid.


Q: Does Sedergine Vit-C help with tiredness or fatigue?

Regulatory documents indicate that the primary use of this product is for the symptomatic relief of pain and fever. While the Ascorbic Acid component is included as a vitamin to support general well-being, the official therapeutic indication does not specifically list the treatment of tiredness or fatigue.


Q: How long do the effects of Sedergine Vit-C last?

The duration of the therapeutic effects is taken into account in the official administration instructions. These guidelines specify that doses should be separated by a required interval of 4 to 8 hours. This interval is established based on the duration of effect and safety considerations related to the maximum amount that may be used daily.


Q: Can Sedergine Vit-C cause stomach upset or acid reflux?

The official safety profile documents that gastrointestinal disorders are among the most commonly reported effects, including nausea, vomiting, abdominal cramps, and diarrhea. Official administration instructions emphasize that the medicine must not be taken on an empty stomach, which is intended to help limit the potential for gastrointestinal upset.


Q: Are there certain foods or drinks that should be avoided when using Sedergine Vit-C?

Regulatory documents state that co-administration with Ethanol (Alcohol) is noted to increase the risk of gastrointestinal bleeding when used with the product. Additionally, the administration instructions require that the effervescent tablet is dissolved and taken not on an empty stomach.


Q: Is Sedergine Vit-C safe for people with high blood pressure?

Regulatory documentation notes that the Acetylsalicylic Acid (ASA) component may diminish the effect of some medications used to treat high blood pressure (antihypertensives). Furthermore, conditions such as uncontrolled severe heart failure are listed as contraindications. Official guidance is necessary to determine the appropriate use of the product for individuals with high blood pressure.


Q: Can individuals with a history of kidney stones use Sedergine Vit-C?

Official information lists Nephrolithiasis (kidney stones) as an absolute contraindication for use. For those who are at risk of forming kidney stones, the intake is restricted to below 1 gram of Ascorbic Acid daily, as high doses may contribute to the formation of renal oxalate calculi.


Q: What are the rules about Sedergine Vit-C use for children?

Official regulatory guidelines specify that standard dosing of Sedergine Vit-C is intended for individuals over 15 years of age. It is officially not recommended for children and adolescents under 16 years of age who have a feverish illness, due to the recognized risk of Reye's Syndrome.


Q: Where is the full list of ingredients for Sedergine Vit-C usually found?

The full list of ingredients is required to be documented in official regulatory materials, such as the Summary of Product Characteristics (SmPC) and the Patient Information Leaflet. This list includes both the active components and all excipients (inactive components) used in the formulation.


Q: Does Sedergine Vit-C contain sugar or artificial sweeteners?

The official documentation for the product, such as the SmPC, details all excipients (inactive ingredients) used in the tablet formulation. The presence or absence of specific components like sugars or artificial sweeteners would be determined by consulting this full list of excipients.


Q: Can Sedergine Vit-C be used if someone has asthma?

Official regulatory documents list a history of asthma induced by Acetylsalicylic Acid (ASA) or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as an absolute contraindication. Individuals with a known sensitivity to these substances are advised against using the product.


Q: Are there warnings about driving or operating machinery while using Sedergine Vit-C?

Regulatory labels are required to explicitly state if the product is known to affect the ability to drive or use machinery. The product’s safety profile must be reviewed for any potential central nervous system effects that would necessitate restrictions on these activities.


Q: Is Sedergine Vit-C habit-forming or addictive?

Sedergine Vit-C is not classified as a controlled substance in regulatory documentation. Regulatory warnings do indicate that prolonged use of any analgesic may potentially lead to a condition known as medication overuse headache.


Q: What happens if someone accidentally uses more Sedergine Vit-C than recommended?

Official regulatory documents contain a dedicated section on overdose (toxicity and management). This section details the potential adverse effects and the necessary clinical actions to take if the recommended maximum dose is accidentally exceeded.


Q: Is there a link between Sedergine Vit-C and tinnitus (ringing in the ears)?

Tinnitus is a recognized symptom of salicylate toxicity and is listed in regulatory documents as a potential undesirable effect. This effect is particularly associated with higher doses of the Acetylsalicylic Acid (ASA) component.


Q: Does Sedergine Vit-C lose its potency over time?

The product's shelf life is established by the manufacturer and is indicated by the expiration date on the packaging. Official storage instructions require that the product must be kept in the original, tightly closed container and protected from moisture and light to ensure its quality and strength are maintained until the expiration date.


Q: Does Sedergine Vit-C interact with herbal supplements?

The regulatory documents explicitly mention the potential for interaction with 'Herbal Products with anti-hemostatic properties.' These substances can increase the likelihood of bleeding when used concurrently with the Acetylsalicylic Acid component of the product.


Q: Is it necessary to finish the entire pack of Sedergine Vit-C if symptoms improve quickly?

Official guidance defines this product for as-needed (prn) use for acute symptoms. It is not a course-based medicine like an antibiotic, but self-treatment with the product is officially limited to a maximum duration of four consecutive days.


Q: Is it safe to drink alcohol while taking Sedergine Vit-C?

Official regulatory documents note that co-administration with Ethanol (Alcohol) increases the risk of gastrointestinal bleeding. This information is a safety consideration noted in the interaction section of the product labeling.


Q: Does the effervescence of Sedergine Vit-C affect how it works?

The effervescent form requires that the tablet be dissolved in water before ingestion. This is noted in regulatory information to facilitate absorption and gastric tolerability. The formulation's high sodium content is also noted in official warnings as a safety consideration for patients on sodium-controlled diets.


Q: Is Sedergine Vit-C vegetarian or vegan-friendly?

The determination of whether the product is suitable for vegetarian or vegan diets depends on the exact formulation's excipients (inactive ingredients). The official Summary of Product Characteristics (SmPC) lists all excipients, which would be the authoritative source to check for the presence of any animal-derived components.


Q: What is the importance of the time of day when using Sedergine Vit-C?

Official instructions specify that the medicine should not be taken on an empty stomach, connecting use to meals or food intake. The time of day itself is not a critical factor, but doses must adhere to the required minimum separation of 4 to 8 hours.

Advertisements

How should Sedergine Vit-C be stored and disposed of?

How to Store and Dispose of Sedergine Vit-C

Official instructions for Sedergine Vit-C (Acetylsalicylic Acid and Ascorbic Acid effervescent tablets) strictly govern its storage and disposal to maintain product quality.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically below 25 C or 30 C.
Protection Must be protected from light and stored in a dry place; the container must be kept tightly closed.
Packaging Store in the original container to protect it from moisture and degradation.
Child Safety Keep out of the reach and sight of children at all times.
Prohibited Do not freeze and do not use after the expiration date.

Disposal Instructions

Unused or expired Sedergine Vit-C must be disposed of according to local regulations. The preferred method is using a community drug take-back program. If one is unavailable, dispose of the product in the household trash after mixing it with an undesirable substance (e.g., kitty litter) and securing it in a sealed bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sedergine Vit-C found in:

A-Z Index: